FDA investigating hospitalizations linked to counterfeit Ozempic
The U.S. Food and Drug Administration has received at least three reports of people being hospitalized after taking counterfeit versions of the wildly popular weight-loss drugs known as semaglutides.
Nov 8, 2023
0
0